Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hoyer

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|October 16, 2019
Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosaMaytham Hussein, Mei-Ling Han, Yan Zhu, et al.
Journal of Receptor and Signal Transduction Research|November 23, 2006
Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disordersDaniel Hoyer, Deepak R Thakker, François Natt, et al.
Frontiers in Neuroscience|December 26, 2013
Distinct effects of IPSU and suvorexant on mouse sleep architectureDaniel Hoyer, Thomas Dürst, Markus Fendt, et al.
Psychopharmacology|February 27, 2016
Editorial: Reporting guidelines for psychopharmacologyThomas Steckler, H Valerie Curran, Harriet de Wit, et al.
Neurobiology of Aging|December 24, 2025
PS19 mouse tauopathy is associated with sex-dependent sleep loss and hyperarousal, and predicts cognitive performanceJarrah O Z J Kron, Jeremy A Metha, Heather J Daykin, et al.
Msystems|May 28, 2020
The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics StudyMaytham Hussein, John A Karas, Elena K Schneider-Futschik, et al.
Annals of the New York Academy of Sciences|December 4, 2019
Synthesis and structure-activity relationships of teixobactinJohn A Karas, Fan Chen, Elena K Schneider-Futschik, et al.
Plos One|October 20, 2021
Rise of the war machines: Charting the evolution of military technologies from the Neolithic to the Industrial RevolutionPeter Turchin, Daniel Hoyer, Andrey Korotayev, et al.
Behavioural Brain Research|September 11, 2022
Altered EEG power spectrum, but not sleep-wake architecture, in HCN1 knockout miceLauren E Bleakley, Ryan J Keenan, Rachel D Graven, et al.
Molecular Neurodegeneration|June 24, 2010
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's diseaseJonathan H Fox, Teal Connor, Vanita Chopra, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|October 16, 2019
Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosaMaytham Hussein, Mei-Ling Han, Yan Zhu, et al.
Journal of Receptor and Signal Transduction Research|November 23, 2006
Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disordersDaniel Hoyer, Deepak R Thakker, François Natt, et al.
Frontiers in Neuroscience|December 26, 2013
Distinct effects of IPSU and suvorexant on mouse sleep architectureDaniel Hoyer, Thomas Dürst, Markus Fendt, et al.
Psychopharmacology|February 27, 2016
Editorial: Reporting guidelines for psychopharmacologyThomas Steckler, H Valerie Curran, Harriet de Wit, et al.
Neurobiology of Aging|December 24, 2025
PS19 mouse tauopathy is associated with sex-dependent sleep loss and hyperarousal, and predicts cognitive performanceJarrah O Z J Kron, Jeremy A Metha, Heather J Daykin, et al.
Msystems|May 28, 2020
The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics StudyMaytham Hussein, John A Karas, Elena K Schneider-Futschik, et al.
Annals of the New York Academy of Sciences|December 4, 2019
Synthesis and structure-activity relationships of teixobactinJohn A Karas, Fan Chen, Elena K Schneider-Futschik, et al.
Plos One|October 20, 2021
Rise of the war machines: Charting the evolution of military technologies from the Neolithic to the Industrial RevolutionPeter Turchin, Daniel Hoyer, Andrey Korotayev, et al.
Behavioural Brain Research|September 11, 2022
Altered EEG power spectrum, but not sleep-wake architecture, in HCN1 knockout miceLauren E Bleakley, Ryan J Keenan, Rachel D Graven, et al.
Molecular Neurodegeneration|June 24, 2010
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's diseaseJonathan H Fox, Teal Connor, Vanita Chopra, et al.
Pageof 16